Sangamo Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMO and other ETFs, options, and stocks.About SGMO
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases.
SGMO Key Statistics
Stock Snapshot
Sangamo Therapeutics(SGMO) stock is priced at $0.52, giving the company a market capitalization of 177.23M. It carries a P/E multiple of -1.16.
On 2025-11-11, Sangamo Therapeutics(SGMO) stock moved within a range of $0.50 to $0.53. With shares now at $0.52, the stock is trading +4.1% above its intraday low and -2.1% below the session's peak.
Trading activity shows a volume of 684.23K, compared to an average daily volume of 5.32M.
The stock's 52-week range extends from a low of $0.41 to a high of $3.01.
The stock's 52-week range extends from a low of $0.41 to a high of $3.01.
SGMO News
Sangamo Therapeutics recently reported its third-quarter 2025 results, revealing a sharp year-over-year revenue decline to US$581,000 and a net loss of US$34.93...
Earnings Call Insights Sangamo targets Q1 2026 BLA submission for Fabry gene therapy as FDA affirms accelerated pathway Nov. 06, 2025 11:56 PM ET Sangamo Therap...
